Search research articles
Contact Us
Filters
Showing results (71-80 of 124) with videos related to
Page
of 13
Sort By:
Cells
|
November 11, 2022
CXCR4-CXCL12-CXCR7 and PD-1/PD-L1 in Pancreatic Cancer: CXCL12 Predicts Survival of Radically Resected Patients
Crescenzo D'Alterio, Alessandro Giardino, Giosuè Scognamiglio, et al.
Cancer Immunology, Immunotherapy : CII
|
February 5, 2005
Prospective clinical trials of biotherapies in solid tumors: a 5-year survey
Alessandro Ottaiano, Ernesto Mollo, Giuseppe Di Lorenzo, et al.
Cellular & Molecular Immunology
|
November 4, 2014
CXCR4 expression affects overall survival of HCC patients whereas CXCR7 expression does not
Maria Neve Polimeno, Caterina Ierano, Crescenzo D'Alterio, et al.
Oncotarget
|
November 5, 2017
Targeting CXCR4 reverts the suppressive activity of T-regulatory cells in renal cancer
Sara Santagata, Maria Napolitano, Crescenzo D'Alterio, et al.
British Journal of Pharmacology
|
November 26, 2021
Sphingosine-1-phosphate/TGF-β axis drives epithelial mesenchymal transition in asthma-like disease
Maria A Riemma, Ida Cerqua, Barbara Romano, et al.
Journal of Medicinal Chemistry
|
November 11, 2017
Structure-Activity Relationships and Biological Characterization of a Novel, Potent, and Serum Stable C-X-C Chemokine Receptor Type 4 (CXCR4) Antagonist
Salvatore Di Maro, Francesco Saverio Di Leva, Anna Maria Trotta, et al.
International Journal of Cancer
|
December 31, 2013
A prognostic model comprising pT stage, N status, and the chemokine receptors CXCR4 and CXCR7 powerfully predicts outcome in neoadjuvant resistant rectal cancer patients
Crescenzo D'Alterio, Antonio Avallone, Fabiana Tatangelo, et al.
Plos One
|
December 19, 2024
The CXCR4 antagonist R54 targets epithelial-mesenchymal transition (EMT) in human ovarian cancer cells
Daniela Russo, Anna Spina, Luigi Portella, et al.
Cell Cycle (Georgetown, Tex.)
|
March 24, 2009
A point mutation (G574A) in the chemokine receptor CXCR4 detected in human cancer cells enhances migration
Caterina Ierano, Paola Giuliano, Crescenzo D'Alterio, et al.
International Journal of Molecular Sciences
|
August 12, 2022
Tailoring the Structure of Cell Penetrating DNA and RNA Binding Nucleopeptides
Stefano Tomassi, Caterina Ieranò, Alessandra Del Bene, et al.
Page
of 13
Search research articles
Search
Showing results (71-80 of 124) with videos related to
Sort By:
Page
of 13
Cells
|
November 11, 2022
CXCR4-CXCL12-CXCR7 and PD-1/PD-L1 in Pancreatic Cancer: CXCL12 Predicts Survival of Radically Resected Patients
Crescenzo D'Alterio, Alessandro Giardino, Giosuè Scognamiglio, et al.
Cancer Immunology, Immunotherapy : CII
|
February 5, 2005
Prospective clinical trials of biotherapies in solid tumors: a 5-year survey
Alessandro Ottaiano, Ernesto Mollo, Giuseppe Di Lorenzo, et al.
Cellular & Molecular Immunology
|
November 4, 2014
CXCR4 expression affects overall survival of HCC patients whereas CXCR7 expression does not
Maria Neve Polimeno, Caterina Ierano, Crescenzo D'Alterio, et al.
Oncotarget
|
November 5, 2017
Targeting CXCR4 reverts the suppressive activity of T-regulatory cells in renal cancer
Sara Santagata, Maria Napolitano, Crescenzo D'Alterio, et al.
British Journal of Pharmacology
|
November 26, 2021
Sphingosine-1-phosphate/TGF-β axis drives epithelial mesenchymal transition in asthma-like disease
Maria A Riemma, Ida Cerqua, Barbara Romano, et al.
Journal of Medicinal Chemistry
|
November 11, 2017
Structure-Activity Relationships and Biological Characterization of a Novel, Potent, and Serum Stable C-X-C Chemokine Receptor Type 4 (CXCR4) Antagonist
Salvatore Di Maro, Francesco Saverio Di Leva, Anna Maria Trotta, et al.
International Journal of Cancer
|
December 31, 2013
A prognostic model comprising pT stage, N status, and the chemokine receptors CXCR4 and CXCR7 powerfully predicts outcome in neoadjuvant resistant rectal cancer patients
Crescenzo D'Alterio, Antonio Avallone, Fabiana Tatangelo, et al.
Plos One
|
December 19, 2024
The CXCR4 antagonist R54 targets epithelial-mesenchymal transition (EMT) in human ovarian cancer cells
Daniela Russo, Anna Spina, Luigi Portella, et al.
Cell Cycle (Georgetown, Tex.)
|
March 24, 2009
A point mutation (G574A) in the chemokine receptor CXCR4 detected in human cancer cells enhances migration
Caterina Ierano, Paola Giuliano, Crescenzo D'Alterio, et al.
International Journal of Molecular Sciences
|
August 12, 2022
Tailoring the Structure of Cell Penetrating DNA and RNA Binding Nucleopeptides
Stefano Tomassi, Caterina Ieranò, Alessandra Del Bene, et al.
Page
of 13